5 research outputs found
Enhancement by streptozotocin of Oâ2 radical generation by the xanthine oxidase system of pancreatic β-cells
AbstractSpin-trapping techniques and electron spin resonance (ESR) spectroscopy were used to study the relationship between the effect of streptozotocin (STZ) on pancreatic β-cells and free radical formation by these cells. Results showed that STZ enhanced generation of the DMPO-OH radical adduct, which is a degradation product of the superoxide anion (Oâ2) in the presence of cellular components, in a hypoxanthine-xanthine oxidase (XOD) system with a homogenate of β-cells. This enhancing effect was also observed in a system without cellular components; STZ increased the signal height due to the Oâ2 radical in a concentration-dependent manner and caused a maximum of 150% enhancement at a concentration of 1.5 mM. Thus, STZ seemed to enhance the generation of the Oâ2 radical in the XOD system, probably by some mechanism of its interaction with XOD. Pancreatic β-cells exhibited a high XOD activity and a very low superoxide dismutase activity. Therefore, the present result supports the possibility that the cytotoxic effect of STZ is closely related to free radical generation in pancreatic β-cells
5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation
A drug for metastasis prevention is necessary. The orally administered anticancer drug Sâ1 contributes to cancer therapy. In a mouse xenograft model of metastatic breast cancer from our previous study, the administration of Sâ1 inhibited lung metastasis. However, the mechanism of inhibition remains elusive. Sâ1 contains 5âchloroâ2, 4âdihydroxypyridine (CDHP), which does not have the antigrowth activity, but prevents the degradation of 5âfluorouracil, an anticancer reagent. In this study, we found that CDHP treatment shrinks cell morphology in metastatic basalâlike breast cancer cell lines. Wound healing assays showed reduced cell migration in CDHPâtreated cells. At the molecular level, CDHP treatment reduced the number of nascent adhesions, whereas the number of mature focal adhesions was not changed. These findings indicate that CDHP impairs focal adhesion formation, which results in a reduction in cell migration. For the in vivo metastasis assay, we used a highly lungâmetastatic cell line. We xenografted them into immunodeficient mice, and administered CDHP. To determine whether CDHP prevents metastasis, we measured the weights of harvested lungs. The results showed that the lung weights of the CDHPâtreated animals were not significantly different compared to the noâtumor controls, whereas the vehicle group showed a number of metastatic foci and an increase in lung weight. These observations indicate that CDHP administration prevents metastasis. This study reveals a novel effect of CDHP for lung metastasis prevention. Our findings may facilitate the establishment of future metastasis prevention therapies